What you both fail to understand is that manufacturing has always been the Achilles heel for this enterprise and I believe LP's vision was to see DCVAX take its rightful place as a platform technology. She has talked about platform technology for many years and had we had her foresight regarding manufacturing we would have known that until a solution was found gaining platform status was a pipe dream. The beauty now is that we are close to a solution and this will translate to an exponentially different valuation moving forward. The price of your shares will be based on completely different targets compared to those that the bears were hoping for with regard the manual process and the limitations that come with that. Good luck to you both but my thinking your luck is about to change.
Market Data 
Markets 
AI
